RECENT FUNDING
  1. Recent Funding
  2. Companies
  3. Triumvira Immunologics

Triumvira Immunologics

Triumvira Immunologics is an immunotherapy company that develops novel T cell therapies for cancer.

Latest funding

$45M Series A ·

Led by B Capital · Source: startupintros.com

Total raised: $100M across 2 sourced rounds

All 2 rounds ↓
Website: triumvira.com.
X: @Triumvirainc · 57 followers.
LinkedIn: linkedin.com.
Category: Health and bio.
Sectors: Biotechnology, Clinical Trials, Health Care.
Stage: Series A.
Based in: San Francisco, United States.
Total raised: $100M in 2 sourced rounds.
Last round: Mar 17, 2022 · 1,706 days ago.
Headcount: 11–50 employees.
On Recent Funding since: Nov 16, 2026.

Signals

X account@Triumvirainc · created Dec 19, 2022 (3 years old) · 57 followers
Website registeredJan 22, 2005 (21 years old)
TIMELINE · MONEY RAISED

Triumvira Immunologics | 2299 days on the record

@Triumvirainc·Raised $100M in 2 sourced rounds
$25M$50M$75M$100MAUGJUNAPRFEBDECOCTAUGJUN$100M$55M Series A · Aug 1, 2020$55M A · AUG '20$45M Series A · Mar 17, 2022$45M A · MAR '22||X ACCOUNT CREATED @TRIUMVIRAINC · DEC 19, 2022

Money raised, round by round (amounts linked to their source). Pins are dated signals; hover the icons for dates.

Funding rounds

DateRoundAmountLeadSource
Series A$45MBB Capitalstartupintros.com
Series A$55MLLeaps by Bayerstartupintros.com

Timeline

  1. X account created
  2. Website created

Founders and team

Investors

Companies like Triumvira Immunologics

Other companies backed by B Capital

B Capital portfolio →

Sources and API

Every amount links to the page it came from. * Estimated from an accelerator's published standard deal, not a company-specific disclosure. How Recent Funding sources and verifies funding data. The same data as JSON: /api/v1/companies/triumvira-immunologics (get a free API key).

Top raises, every week

The week's top funded startups and market insights, in your inbox every Monday.

Unsubscribe anytime · privacy